The University of Queensland

Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Jenkins, Aaron, Atreja, Nipun, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin, Sun, Xiaoxi and Lip, Gregory Y.H. (2023). Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study. European Journal of Internal Medicine, 108, 37-42. doi: 10.1016/j.ejim.2022.10.021

Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2)

Deitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Correction: Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID‑19 in the United States: a retrospective cohort study (Journal of Thrombosis and Thrombolysis, (2022), 53, 4, (766-776), 10.1007/s11239-022-02644-2). Journal of Thrombosis and Thrombolysis, 54 (4), 696-696. doi: 10.1007/s11239-022-02708-3

Payer formulary exclusions of apixaban: how patients respond and potential implications

Deitelzweig, Steven, Terasawa, Emi, Kang, Amiee, Atreja, Nipun, Hines, Dionne M., Noman, Ahmed and Luo, Xuemei (2022). Payer formulary exclusions of apixaban: how patients respond and potential implications. Current Medical Research and Opinion, 38 (11), 1-6. doi: 10.1080/03007995.2022.2128189

Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19

Deitelzweig, Steven, Zhu, Julia, Jiang, Jenny, Luo, Xuemei, Keshishian, Allison, Ferri, Mauricio, Rosenblatt, Lisa, Schuler, Patricia, Gutierrez, Cynthia and Dhamane, Amol D. (2022). Impact of apixaban treatment discontinuation on the risk of hospitalization among patients with nonvalvular atrial fibrillation and COVID-19. Current Medical Research and Opinion, 38 (11), 1891-1896. doi: 10.1080/03007995.2022.2112871

Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants

Lip, Gregory Y. H., Murphy, Richard R., Sahiar, Farhad, Ingall, Timothy J., Dhamane, Amol D., Ferri, Mauricio, Hlavacek, Patrick, Preib, Madison T., Keshishian, Allison, Russ, Cristina, Rosenblatt, Lisa, Yuce, Huseyin and Deitelzweig, Steven (2022). Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants. JAMA Network Open, 5 (8) e2229333, 1-12. doi: 10.1001/jamanetworkopen.2022.29333

Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases

Lip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Luo, Xuemei, Atreja, Nipun, Zhang, Yan, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2022). Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: a retrospective analysis of administrative claims databases. Journal of Thrombosis and Thrombolysis, 54 (1), 33-46. doi: 10.1007/s11239-022-02660-2

Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study

Deitelzweig, Steve, Luo, Xuemei, Nguyen, Jennifer L., Malhotra, Deepa, Emir, Birol, Russ, Cristina, Li, Xiaoyan, Lee, Theodore C., Ferri, Mauricio, Wiederkehr, Danny, Reimbaeva, Maya, Barnes, Geoffrey D. and Piazza, Gregory (2022). Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study. Journal of Thrombosis and Thrombolysis, 53 (4), 766-776. doi: 10.1007/s11239-022-02644-2

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

Deitelzweig, Steve, Sah, Janvi, Kang, Amiee, Russ, Cristina, Preib, Madison, Dhamane, Amol D., Ratiu, Anna, Cato, Matthew, Alfred, Tamuno, Levi, Edi and Di Fusco, Manuela (2022). Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs. American Journal of Cardiology, 163, 43-49. doi: 10.1016/j.amjcard.2021.09.047

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

Deitelzweig, Steven, Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y.H. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC: CardioOncology, 3 (3), 411-424. doi: 10.1016/j.jaccao.2021.06.004

Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy

Lip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy. European Heart Journal - Cardiovascular Pharmacotherapy, 7 (5), 405-414. doi: 10.1093/ehjcvp/pvaa117

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding

Lip, Gregory Y. H., Keshishian, Allison V., Zhang, Yan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Ferri, Mauricio, Jiang, Jenny, Yuce, Huseyin and Deitelzweig, Steven (2021). Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients with High Risk of Gastrointestinal Bleeding. JAMA Network Open, 4 (8) e2120064, 1-14. doi: 10.1001/jamanetworkopen.2021.20064

Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Klem, Christian, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity. Advances in Therapy, 38 (6), 3166-3184. doi: 10.1007/s12325-021-01724-8

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients

Deitelzweig, Steven, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Jiang, Jenny, Yuce, Huseyin and Lip, Gregory Y. H. (2021). Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients. Therapeutic Advances in Gastroenterology, 14. doi: 10.1177/1756284821997352

Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis

Deitelzweig, Steven, Di Fusco, Manuela, Kang, Amiee, Savone, Mirko, Mokgokong, Ruth, Keshishian, Allison, Gutierrez, Cynthia and Cappelleri, Joseph C. (2021). Real-world persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. Current Medical Research and Opinion, 37 (6), 891-902. doi: 10.1080/03007995.2021.1897555

Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants

Lip, G. Y. H. and Deitelzweig, S. B. (2021). Response to a letter by Jolobe: ARISTOPHANES subgroup analysis of frail and older patients with NVAF receiving low doses of novel oral anticoagulants. Journal of Internal Medicine, 290 (1), 221-222. doi: 10.1111/joim.13296

Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study

Hill, Jason B., Garcia, David, Crowther, Mark, Savage, Bryan, Peress, Shira, Chang, Kevin and Deitelzweig, Steven (2020). Frequency of venous thromboembolism in 6513 patients with COVID-19: A retrospective study. Blood Advances, 4 (21), 5373-5377. doi: 10.1182/bloodadvances.2020003083

Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

Deitelzweig, Steven B., Lovelace, Belinda, Christoph, Mary, Lingohr-Smith, Melissa, Lin, Jay and Fermann, Gregory J. (2020). Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA. Advances in Therapy, 37 (9), 3942-3953. doi: 10.1007/s12325-020-01440-9

Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study

Lip, G. Y.H., Keshishian, A. V., Kang, A. L., Dhamane, A. D., Luo, X., Li, X., Balachander, N., Rosenblatt, L., Mardekian, J., Pan, X., Di Fusco, M., Garcia Reeves, A. B., Yuce, H. and Deitelzweig, S. (2020). Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study. Journal of Internal Medicine, 289 (1) joim.13140, 42-52. doi: 10.1111/joim.13140

Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study

Deitelzweig, Steve, Keshishian, Allison, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Li, Xiaoyan, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Di Fusco, Manuela, Reeves, Alessandra B. Garcia, Yuce, Huseyin and Lip, Gregory Y. H. (2020). Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study. Journal of Clinical Medicine, 9 (6) 1633, 1-25. doi: 10.3390/jcm9061633

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Lip, Gregory Y.H., Keshishian, Allison V., Kang, Amiee L., Li, Xiaoyan, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Nadkarni, Anagha, Pan, Xianying, Di Fusco, Manuela, Garcia Reeves, Alessandra B., Yuce, Huseyin and Deitelzweig, Steven B. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Mayo Clinic Proceedings, 95 (5), 929-943. doi: 10.1016/j.mayocp.2019.05.032

Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative

Barkoudah, Ebrahim, Piazza, Gregory, Hecht, Todd E. H., Grant, Paul, Deitelzweig, Steven, Fang, Margaret C., Fanikos, John, Kao, Cheng-Kai, Barnes, Geoffrey D., Chen, Thomas, Ramishvili, Tea, Schnipper, Jeffrey L., Goldstein, Jennifer N., Ruff, Christian T., Kaatz, Scott, Schwartz, Aviva, Connors, Jean M. and Goldhaber, Samuel Z. (2020). Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. American Journal of Medicine, 133, 1-27. doi: 10.1016/j.amjmed.2019.12.001

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States

Deitelzweig, Steven, Baker, Christine L., Dhamane, Amol D., Mardekian, Jack, Dina, Oluwaseyi, Rosenblatt, Lisa, Russ, Cristina, Poretta, Tayla, Lingohr-Smith, Melissa and Lin, Jay (2020). Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States. Journal of Drug Assessment, 9 (1), 87-96. doi: 10.1080/21556660.2020.1750418

Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants

Fermann, Gregory J., Lovelace, Belinda, Christoph, Mary J., Lingohr-Smith, Melissa, Lin, Jay and Deitelzweig, Steven B. (2020). Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants. Journal of Medical Economics, 23 (12), 1409-1417. doi: 10.1080/13696998.2020.1837502

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

Deitelzweig, Steven, Dhamane, Amol D., Di Fusco, Manuela, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa and Lin, Jay (2020). Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA. Journal of Medical Economics, 23 (12), 1-12. doi: 10.1080/13696998.2020.1832099

Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom

Guy, Holly, Laskier, Vicki, Fisher, Mark, Bucior, Iwona, Deitelzweig, Steven and Cohen, Alexander T. (2019). Budget impact analysis of betrixaban for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United Kingdom. Expert Review of Pharmacoeconomics and Outcomes Research, 20 (3), 1-9. doi: 10.1080/14737167.2019.1629905

Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States

Guy, Holly, Laskier, Vicki, Fisher, Mark, Neuman, W. Richey, Bucior, Iwona, Deitelzweig, Steven and Cohen, Alexander T. (2019). Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States. Pharmacoeconomics, 37 (5), 701-714. doi: 10.1007/s40273-018-0757-8

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

Amin, Alpesh, Deitelzweig, Steven, Bucior, Iwona, Lin, Jay, Lingohr-Smith, Melissa, Menges, Brandy and Neuman, W. Richey (2019). Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US. Journal of Medical Economics, 22 (11), 1-7. doi: 10.1080/13696998.2019.1618862

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Deitelzweig, Steven, Keshishian, Allison, Li, Xiaoyan, Kang, Amiee, Dhamane, Amol D., Luo, Xuemei, Balachander, Neeraja, Rosenblatt, Lisa, Mardekian, Jack, Pan, Xianying, Nadkarni, Anagha, Di Fusco, Manuela, Garcia Reeves, Alessandra B., Yuce, Huseyin and Lip, Gregory Y. H. (2019). Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients. Journal of the American Geriatrics Society, 67 (8) jgs.15956, 1662-1671. doi: 10.1111/jgs.15956

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review

Deitelzweig, Steve and Lip, Gregory Y. H. (2019). Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review. Expert Review of Pharmacoeconomics and Outcomes Research, 19 (3), 1-2. doi: 10.1080/14737167.2019.1592834

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study

Lip, Gregory Y. H., Keshishian, Allison, Li, Xiaoyan, Hamilton, Melissa, Masseria, Cristina, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying, Baser, Onur and Deitelzweig, Steven (2018). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study. Stroke, 49 (12), 2933-2944. doi: 10.1161/STROKEAHA.118.020232

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States

Deitelzweig, Steven, Guo, Jennifer D., Hlavacek, Patrick, Lin, Jay, Wygant, Gail, Rosenblatt, Lisa, Gupta, Anu, Pan, Xianying, Mardekian, Jack, Lingohr-Smith, Melissa, Menges, Brandy, Marshall, Alexander and Nadkarni, Anagha (2018). Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States. Clinical and Applied Thrombosis-Hemostasis, 24 (9_suppl), 261S-268S. doi: 10.1177/1076029618800806

Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States

Deitelzweig, Steven B., Evans, Michael, Trocio, Jeffrey, Gupta, Kiran, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2018). Impact of warfarin persistence on health-care utilization and costs among patients with atrial fibrillation managed in anticoagulation clinics in the United States. Clinical and Applied Thrombosis-Hemostasis, 24 (2), 364-371. doi: 10.1177/1076029616685427

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

Deitelzweig, Steve, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Hlavacek, Patrick, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2018). All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants. Clinical and Applied Thrombosis/Hemostasis, 24 (4), 1076029617750269-611. doi: 10.1177/1076029617750269

Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach

Li, Xiaoyan, Keshishian, Allison, Hamilton, Melissa, Horblyuk, Ruslan, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying, Lip, Gregory Y. H. and Deitelzweig, Steve (2018). Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PLoS One, 13 (1) e0191722, e0191722. doi: 10.1371/journal.pone.0191722

Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation

Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation. Journal of Managed Care & Specialty Pharmacy, 23 (11), 1191-1201. doi: 10.18553/jmcp.2017.17060

Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients

Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Curtice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients. Current Medical Research and Opinion, 33 (10), 1745-1754. doi: 10.1080/03007995.2017.1334638

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Deitelzweig, Steven, Neuman, W. Richey, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. Journal of Medical Economics, 20 (12), 1217-1223. doi: 10.1080/13696998.2017.1362412

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice: a propensity-matched analysis of 76,940 patients

Li, Xiaoyan, Deitelzweig, Steve, Keshishian, Allison, Hamilton, Melissa, Horblyuk, Ruslan, Gupta, Kiran, Luo, Xuemei, Mardekian, Jack, Friend, Keith, Nadkarni, Anagha, Pan, Xianying and Lip, Gregory Y. H. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in "real-world" clinical practice: a propensity-matched analysis of 76,940 patients. Thrombosis and Haemostasis, 117 (6), 1072-1082. doi: 10.1160/TH17-01-0068

Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin

Margolis, Jay M., Deitelzweig, Steven, Kline, Jeffrey, Tran, Oth, Smith, David M., Crivera, Concetta, Bookhart, Brahim and Schein, Jeff (2016). Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin. Clinical Therapeutics, 38 (11), 2496-2503. doi: 10.1016/j.clinthera.2016.09.007

Shorter hospital stays and lower costs for rivaroxaban compared with warfarin for venous thrombosis admissions

Margolis, Jay M., Deitelzweig, Steven, Kline, Jeffrey, Tran, Oth, Smith, David M., Bookhart, Brahim, Crivera, Concetta and Schein, Jeff (2016). Shorter hospital stays and lower costs for rivaroxaban compared with warfarin for venous thrombosis admissions. Journal of the American Heart Association, 5 (10) e003788. doi: 10.1161/JAHA.116.003788

Hospitalizations and other health care resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting

Deitelzweig, Steven, Laliberte, Francois, Crivera, Concetta, Germain, Guillaume, Bookhart, Brahim K., Olson, William H., Schein, Jeffrey and Lefebvre, Patrick (2016). Hospitalizations and other health care resource utilization among patients with deep vein thrombosis treated with rivaroxaban versus low-molecular-weight heparin and warfarin in the outpatient setting. Clinical Therapeutics, 38 (8), 1803-1816. doi: 10.1016/j.clinthera.2016.07.002

Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options

Cerceo, Elizabeth, Deitelzweig, Steven B., Sherman, Bradley M. and Amin, Alpesh N. (2016). Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, implications for clinical practice, and emerging treatment options. Microbial Drug Resistance, 22 (5), 412-431. doi: 10.1089/mdr.2015.0220

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation

Deitelzweig, Steve, Evans, Michael, Hillson, Eric, Trocio, Jeffrey, Bruno, Amanda, Tan, Wilson, Lingohr-Smith, Melissa, Singh, Prianka and Lin, Jay (2016). Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation. Current Medical Research and Opinion, 32 (1), 87-94. doi: 10.1185/03007995.2015.1103217

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

McHorney, Colleen A., Crivera, Concetta, Laliberte, Francois, Nelson, Winnie W., Germain, Guillaume, Bookhart, Brahim, Martin, Silas, Schein, Jeffrey, Lefebvre, Patrick and Deitelzweig, Steven (2015). Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure. Current Medical Research and Opinion, 31 (12), 2167-2173. doi: 10.1185/03007995.2015.1096242

A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: Balancing the risks and benefits

Amin, Alpesh and Deitelzweig, Steven (2015). A case-based approach to implementing guidelines for stroke prevention in patients with atrial fibrillation: Balancing the risks and benefits. Thrombosis Journal, 13 (29) 29, 29. doi: 10.1186/s12959-015-0056-y

Comparison of medical costs of patients with atrial fibrillation unsuitable for warfarin treatment with apixaban or aspirin based on averroes trial

Amin, Alpesh, Deitelzweig, Steve, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2015). Comparison of medical costs of patients with atrial fibrillation unsuitable for warfarin treatment with apixaban or aspirin based on averroes trial. Clinical and Applied Thrombosis/Hemostasis, 21 (3), 235-240. doi: 10.1177/1076029613507335

Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database

Deitelzweig, Steven B., Jing, Yonghua, Swindle, Jason P. and Makenbaeva, Dinara (2014). Reviewing a clinical decision aid for the selection of anticoagulation treatment in patients with nonvalvular atrial fibrillation: applications in a US managed care health plan database. Clinical Therapeutics, 36 (11), 1566-1573. doi: 10.1016/j.clinthera.2014.09.016

Hospitalist perspective on the treatment of skin and soft tissue infections

Amin, Alpesh N., Cerceo, Elizabeth A., Deitelzweig, Steven B., Pile, James C., Rosenberg, David J. and Sherman, Bradley M. (2014). Hospitalist perspective on the treatment of skin and soft tissue infections. Mayo Clinic Proceedings, 89 (10), 1436-1451. doi: 10.1016/j.mayocp.2014.04.018

Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials

Amin, Alpesh, Deitelzweig, Steve, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2014). Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials. Journal of Thrombosis and Thrombolysis, 38 (2), 150-159. doi: 10.1007/s11239-013-1048-z

Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation

Deitelzweig, Steven (2014). Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation. Cardiovascular Therapeutics, 32 (2), 74-81. doi: 10.1111/1755-5922.12048

The key principles and characteristics of an effective hospital medicine group: an assessment guide for hospitals and hospitalists

Cawley, Patrick, Deitelzweig, Steven, Flores, Leslie, Miller, Joseph A., Nelson, John, Rissmiller, Scott, Wellikson, Laurence and Whitcomb, Winthrop F. (2014). The key principles and characteristics of an effective hospital medicine group: an assessment guide for hospitals and hospitalists. Journal of Hospital Medicine, 9 (2), 123-128. doi: 10.1002/jhm.2119

The hospitalist perspective on treatment of community-acquired bacterial pneumonia

Amin, Alpesh N., Cerceo, Elizabeth A., Deitelzweig, Steven B., Pile, James C., Rosenberg, David J. and Sherman, Bradley M. (2014). The hospitalist perspective on treatment of community-acquired bacterial pneumonia. Postgraduate Medicine, 126 (2), 18-29. doi: 10.3810/pgm.2014.03.2737

Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population

Deitelzweig, Steven B., Pinsky, Brett, Buysman, Erin, Lacey, Michael, Makenbaeva, Dinara, Wiederkehr, Daniel and Graham, John (2013). Bleeding as an outcome among patients with nonvalvular atrial fibrillation in a large managed care population. Clinical Therapeutics, 35 (10), 1536-1545.e1. doi: 10.1016/j.clinthera.2013.08.013

Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis

Deitelzweig, Steven, Amin, Alpesh, Christian, Rudell, Friend, Keith, Lin, Jay and Lowe, Timothy J. (2013). Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis. Advances in Therapy, 30 (1), 71-80. doi: 10.1007/s12325-012-0073-1

Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US

Amin, Alpesh, Deitelzweig, Steven, Christian, Rudell, Friend, Keith, Lin, Jay, Belk, Kathy, Baumer, Dorothy and Lowe, Timothy J. (2012). Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US. Journal of Hospital Medicine, 7 (8), 634-639. doi: 10.1002/jhm.1973

Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records

Rosenman, Marc B., Baker, Layla, Jing, Yonghua, Makenbaeva, Dinara, Meissner, Brian, Simon, Teresa A., Wiederkehr, Daniel and Deitelzweig, Steve (2012). Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records. Current Medical Research and Opinion, 28 (9), 1407-1414. doi: 10.1185/03007995.2012.708653

Preventing venous thromboembolism following orthopedic surgery in the United States: impact of special populations on clinical outcomes

Deitelzweig, Steven B., Lin, Jay and Lin, Grace (2011). Preventing venous thromboembolism following orthopedic surgery in the United States: impact of special populations on clinical outcomes. Clinical and Applied Thrombosis/Hemostasis, 17 (6), 640-650. doi: 10.1177/1076029611404215

Venous thromboembolism in the US: does race matter?

Deitelzweig, Steven B., Lin, Jay, Johnson, Barbara H. and Schulman, Kathy L. (2011). Venous thromboembolism in the US: does race matter?. Journal of Thrombosis and Thrombolysis, 31 (2), 133-138. doi: 10.1007/s11239-010-0503-3

Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

Deitelzweig, Steven B., Lin, Jay, Kreilick, Charles, Hussein, Mohamed and Battleman, David (2010). Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Advances in Therapy, 27 (9), 634-647. doi: 10.1007/s12325-010-0059-9

Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?

Deitelzweig, Steven B., Lin, Jay, Hussein, Mohamed and Battleman, David (2010). Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?. Journal of Thrombosis and Thrombolysis, 30 (1), 55-66. doi: 10.1007/s11239-009-0393-4

Extended-Duration Venous Thromboembolism Prophylaxis in Acutely III Medical Patients With Recently Reduced Mobility

Hull, Russell D., Schellong, Sebastian M., Tapson, Victor F., Monreal, Manuel, Samama, Meyer-Michel, Nicol, Philippe, Vicaut, Eric, Turpie, Alexander G. G., Yusen, Roger D., EXCLAIM (Extended Prophylaxis for Venous ThromboEmbolism in Acutely Ill Medical Patients With Prolonged Immobilization) study and Deitelzweig, Steven (2010). Extended-Duration Venous Thromboembolism Prophylaxis in Acutely III Medical Patients With Recently Reduced Mobility. Annals of Internal Medicine, 153 (1), 8-+. doi: 10.7326/0003-4819-153-1-201007060-00004

Thrombotic risk and immobility in residents of long-term care facilities

Zarowitz, Barbara J., Tangalos, Eric, Lefkovitz, Allen, Bussey, Henry, Deitelzweig, Steven, Nutescu, Edith, O'Shea, Terrence, Resnick, Barbara and Wheeler, Arthur (2010). Thrombotic risk and immobility in residents of long-term care facilities. Journal of the American Medical Directors Association, 11 (3), 211-221. doi: 10.1016/j.jamda.2009.11.006

Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient

McKean, Sylvia C., Deitelzweig, Steven B., Sasahara, Arthur, Michota, Franklin and Jacobson, Anne (2009). Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient. Journal of Hospital Medicine, 4 (S2), S1-S7. doi: 10.1002/jhm.587

Guidelines-based use of thromboprophylaxis

Deitelzweig, Steven B., Sasahara, Arthur, Michota, Franklin, McKean, Sylvia C. and Jacobson, Anne (2009). Guidelines-based use of thromboprophylaxis. Journal of Hospital Medicine, 4 (S2), S8-S15. doi: 10.1002/jhm.596

Improving thromboprophylaxis: Performance measures and practical strategies

Michota, Franklin, Connor, Patrick J., McKean, Sylvia C., Deitelzweig, Steven B., Sasahara, Arthur and Jacobson, Anne (2009). Improving thromboprophylaxis: Performance measures and practical strategies. Journal of Hospital Medicine, 4 (SUPPL. 2), S24-S30. doi: 10.1002/jhm.564

Optimizing management of venous thromboembolism: diagnosis, treatment, and secondary prevention

Sasahara, Arthur, Michota, Franklin, McKean, Sylvia C., Deitelzweig, Steven B. and Jacobson, Anne (2009). Optimizing management of venous thromboembolism: diagnosis, treatment, and secondary prevention. Journal of Hospital Medicine, 4 (S2), S16-S23. doi: 10.1002/jhm.586

Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism

Deitelzweig, Steven B., Becker, Russ, Lin, Jay and Benner, Josh (2008). Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism. Thrombosis and Haemostasis, 100 (5), 810-820. doi: 10.1160/TH08-04-0248

Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry)

Spyropoulos, Alex C., Turpie, Alexander G. G., Dunn, Andrew S., Kaatz, Scott, Douketis, James, Jacobson, Alan, Petersen, Hans, REGIMEN Investigators and Deitelzweig, Steven (2008). Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry). American Journal of Cardiology, 102 (7), 883-889. doi: 10.1016/j.amjcard.2008.05.042

VTE prevention in major orthopedic surgery - Reply

Deitelzweig, Steven B., Amin, Alpesh N., Brotman, Daniel J., Mckean, Sylvia C., Spyropoulos, Alex C. and Jaffer, Amir K. (2008). VTE prevention in major orthopedic surgery - Reply. Cleveland Clinic Journal of Medicine, 75 (7), 472-473.

Peripheral arterial disease and the hospitalist: the rationale for early detection and optimal therapy

Deitelzweig, Steven B. and Hoekstra, James W. (2008). Peripheral arterial disease and the hospitalist: the rationale for early detection and optimal therapy. Journal of Hospital Medicine, 3 (S2), S4-S8. doi: 10.1002/jhm.325

Anticoagulant prophylaxis in medical patients: An objective assessment

Deitelzweig, S and Groce, JB (2004). Anticoagulant prophylaxis in medical patients: An objective assessment. Pharmacotherapy, 24 (8), 120-126.

CT angiogram of aortic dissection and left renal artery stenosis

Goldman, CK and Deitelzweig, SB (2004). CT angiogram of aortic dissection and left renal artery stenosis. Vascular Medicine, 9 (1), 69-69. doi: 10.1191/1358863x04vm524xx

Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients

Deitelzweig, SB, Vanscoy, GJ, Niccolai, CS and Rihn, TL (2003). Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Annals of Pharmacotherapy, 37 (3), 402-411. doi: 10.1345/aph.1C152

Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis

Chimowitz, M, Howlett-Smith, H, Calcaterra, A, Lessard, N, Stern, B, Lynn, M, Hertzberg, V, Cotsonis, G, Swanson, S, Tutu-Gxashe, T, Griffin, P, Kosinski, A, Chester, C, Asbury, W, Rogers, S, Chimowitz, M, Stern, B, Frankel, M, Howlett-Smith, H, Hertzberg, V, Lynn, M, Levine, S, Chaturvedi, S, Benesch, C, Woolfenden, A, Sila, C, Zweifler, R, Lyden, P, Barnett, H ... Furie, K (2003). Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis. Neuroepidemiology, 22 (2), 106-117. doi: 10.1159/000068744

Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or Warfarin

Deitelzweig, Steven, Luo, Xuemei, Gupta, Kiran, Trocio, Jeffrey, Mardekian, Jack, Cutice, Tammy, Lingohr-Smith, Melissa, Menges, Brandy and Lin, Jay (2017). Real World Evaluation of Major Bleeding Risk and Costs for All Causes and Bleeding-Related Health Services Among Elderly Patients with Nonvalvular Atrial Fibrillation Treated with Apixaban or Warfarin. 66th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Washington DC, United States, Mar 17-19, 2017. San Diego, United States: Elsevier.

An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants

Deitelzweig, Steve, Bruno, Amanda, Trocio, Jeffrey, Tate, Natalie, Gupta, Kiran, Lin, Jay and Lingohr-Smith, Melissa (2016). An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants. Abingdon, Oxfordshire, United Kingdom: Taylor & Francis. doi: 10.1185/03007995.2015.1131676

Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin

Deitelzweig, Steven, Gupta, Kiran, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Eaddy, Michael and Squibb, Bristol-Myers (2016). Compare major bleeding risk and associated costs among Nvaf patients with Cha2Ds2-vasc score >= 3 newly anticoagulated with apixaban versus warfarin. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30877-4

Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stay

Deitelzweig, Steven, Kline, Jeffrey, Margolis, Jay M., Raut, Monika, Tran, Oth, Smith, David, Crivera, Concetta, Bookhart, Brahim, Schein, Jeff and Olson, William (2016). Comparison of rivaroxaban or warfarin use for venous thromboembolism on inpatient length of stay. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)32066-6

Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin

Deitelzweig, S., Laliberte, F., Raut, R., Germain, G., Bookhart, B. K., Olson, W. H., Schein, J. and Lefebvre, P. (2016). Health Care Costs Among Patients Diagnosed with Deep Vein Thrombosis in the Outpatient Setting and Treated with Rivaroxaban Versus Low-Molecular-Weight Heparin and Warfarin. Unknown, Unknown, Unknown. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2016.03.102

Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or Warfarin

Kline, J. A., Deitelzweig, S., Margolis, J. M., Raut, M., Tran, O., Smith, D. M., Crivera, C., Bookhart, B., Schein, J. and Olson, W. (2016). Hospital Length Of Stay And Hospitalization Costs For Pulmonary Embolism Comparing Patients Receiving Rivaroxaban Or Warfarin. International Conference of the American-Thoracic-Society (ATS), San Francisco, United States, May 13-18, 2016. NEW YORK: AMER THORACIC SOC.

Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxaban

Deitelzweig, Steven, Gupta, Kiran, Nadkarni, Anagha, Trocio, Jeffrey, Lin, Jay and Lingohr-Smith, Melissa (2016). Hospital readmissions among patients with nonvalvular atrial fibrillation treated with the new oral anticoagulants, apixaban, dabigatran, and rivaroxaban. 65th Annual Scientific Session and Expo of the American College of Cardiology (ACC), Chicago, United States, April 02-04, 2016. San Diego, United States: Elsevier. doi: 10.1016/S0735-1097(16)30806-3

Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Deitelzweig, S., Neuman, R., Lingohr-Smith, M. and Lin, J. (2016). Hospital resource utilization, cost and inpatient mortality associated with hospitalizations for major bleeding among atrial fibrillation patients treated with factor Xa inhibitors. Congress of the European-Society-of-Cardiology (ESC), Rome Italy, Aug 27-31, 2016. OXFORD: OXFORD UNIV PRESS.

A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.S

Deitelzweig, S., Evans, M., Hillson, E., Trocio, J., Bruno, A., Tan, W., Lingohr-Smith, M. and Lin, J. (2015). A Conservative Aproach to Assess Warfarin Time-in-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients in An Integrated Healthcare Delivery System Setting in the U.S. Unknown, Unknown, Unknown. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/j.jval.2015.03.848

Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients

Deitelzweig, Steven, Bruno, Amanda, Tate, Natalie, Ogbonnaya, Augustina, Shah, Manan, Farrelly, Eileen, Lokhandwala, Tasneem, Gupta, Kiran and Eaddy, Michael (2015). Comparison of Major Bleeding Risk and Associated Costs Among Newly Anticoagulated Non-valvular Atrial Fibrillation Patients. Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association (AHA), Orlando, United States, Nov 07-11, 2015. LIPPINCOTT WILLIAMS & WILKINS.

Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US

Deitelzweig, S., Bruno, A., Trocio, J., Tate, N., Gupta, K., Lin, J. and Lingohr-Smith, M. (2015). Early assessment of bleeding-related hospital readmissions among nonvalvular atrial fibrillation patients treated with the new oral anticoagulants using an electronic medical record database in the US. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS.

Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants

Deitelzweig, S., Bruno, A., Tate, N., Ogbonnaya, A., Shah, M., Farrelly, E., Lokhandwala, T., Gupta, K. and Eaddy, M. (2015). Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants. Congress of the European-Society-of-Cardiology (ESC), London, England, United Kingdom, Aug 29-Sep 02, 2015. OXFORD: OXFORD UNIV PRESS.

Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery

Deitelzweig, Steven, Nutescu, Edith A., Meyer, James, Lin, Jay, Lingohr-Smith, Melissa and Amin, Alpesh N. (2014). Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2014. WASHINGTON: AMER SOC HEMATOLOGY.

Costs of Patients with Nonvalvular Atrial Fibrillation Who Have Bleeding Events in a Large Managed Care Population

Deitelzweig, Steven, Pinsky, Brett, Buysman, Erin, Lacey, Michael, Jing, Yonghua, Wiederkehr, Daniel and Graham, John (2013). Costs of Patients with Nonvalvular Atrial Fibrillation Who Have Bleeding Events in a Large Managed Care Population. 62nd Annual Scientific Session of the American-College-of-Cardiology, San Francisco Ca, Mar 09-11, 2013. ELSEVIER SCIENCE INC.

Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care Population

Deitelzweig, Steven, Pinsky, Brett, Buysman, Erin, Lacey, Michael, Jing, Yonghua, Wiederkehr, Daniel and Graham, John (2012). Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care Population. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta Ga, Dec 08-11, 2012. AMER SOC HEMATOLOGY.

Impact of Hyponatremia On Health Care Resource Utilization in Decompensated Cirrhosis Patients

Deitelzweig, S., Amin, A., Lin, J., Christian, R., Baumer, D. and Lowe, T. (2012). Impact of Hyponatremia On Health Care Resource Utilization in Decompensated Cirrhosis Patients. ELSEVIER SCIENCE INC.

Comparison of Total Medical Cost Avoidance with the Usage of New Oral Anticoagulants Instead of Warfarin Among Atrial Fibrillation Patients, Based On the Aristotle, Re-Ly and Rocket-Af Trials

Deitelzweig, Steven, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2012). Comparison of Total Medical Cost Avoidance with the Usage of New Oral Anticoagulants Instead of Warfarin Among Atrial Fibrillation Patients, Based On the Aristotle, Re-Ly and Rocket-Af Trials. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. ELSEVIER SCIENCE INC.

Total Medical Costs Avoided with Apixaban Versus Aspirin Treatment Among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin, Based On the Averroes Trial Results: Acc Oral Contributions

Amin, Alpesh N., Deitelzweig, Steven, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay and Graham, John (2012). Total Medical Costs Avoided with Apixaban Versus Aspirin Treatment Among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin, Based On the Averroes Trial Results: Acc Oral Contributions. 61st Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), Chicago Il, Mar 24-27, 2012. ELSEVIER SCIENCE INC.

Consequences of Hyponatremia on Intensive Care Unit Cost and Length of Stay in Heart Failure Patients

Amin, Alpesh, Deitelzweig, Steven, Lin, Jay, Belk, Kathy, Baumer, Dorothy and Lowe, Timothy (2011). Consequences of Hyponatremia on Intensive Care Unit Cost and Length of Stay in Heart Failure Patients. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.

Impact of Hyponatremia on Inpatient Mortality and Hospital Readmission Rates in Hospitalized Patients with Heart Failure

Deitelzweig, Steven, Amin, Alpesh, Lin, Jay, Belk, Kathy, Baumer, Dorothy and Lowe, Timothy (2011). Impact of Hyponatremia on Inpatient Mortality and Hospital Readmission Rates in Hospitalized Patients with Heart Failure. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS.

Impact of Hyponatremia On Patient Outcomes and Health Care Resource Utilization in Hospitalized Patients

Deitelzweig, S., Amin, A., Lin, J., Belk, K., Baumer, D. and Lowe, T. (2011). Impact of Hyponatremia On Patient Outcomes and Health Care Resource Utilization in Hospitalized Patients. ELSEVIER SCIENCE INC.

Potential Economic Impact of Dyspnea Associated with Ticagrelor Use

Bonafede, M., Jing, Y., Bergeson, Gdovin J., Liffmann, D. K., Makenbaeva, D., Graham, J. P. and Deitelzweig, S. (2011). Potential Economic Impact of Dyspnea Associated with Ticagrelor Use. ELSEVIER SCIENCE INC.

Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures.

Deitelzweig, Steven, Thompson, Stephen, Lin, Jay, McMorrow, Donna and Johnson, Barbara (2010). Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures.. 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando Fl, Dec 04-07, 2010. AMER SOC HEMATOLOGY.

Prevalence of Venous Thromboembolism Across Ethnic Groups in the United States

Deitelzweig, Steven B., Lin, Jay, Johnson, Barbara H. and Schulman, Kathy L. (2009). Prevalence of Venous Thromboembolism Across Ethnic Groups in the United States. 51st Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 05-08, 2009. AMER SOC HEMATOLOGY.

Patterns and Predictors of Warfarin Use in Patients with Venous Thromboembolism

Deitelzweig, Steven B., Hussein, Mohamed, Lin, Jay, Kreilick, Charles and Battleman, David (2008). Patterns and Predictors of Warfarin Use in Patients with Venous Thromboembolism. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2008. AMER SOC HEMATOLOGY.

Comparison of the 2-year clinical outcomes of VTE prophylaxis options in medical patients at risk of VTE

Deitelzweig, Steven B., Lin, Jay, Benner, Josh and Becker, Russ (2007). Comparison of the 2-year clinical outcomes of VTE prophylaxis options in medical patients at risk of VTE. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 08-11, 2007. AMER SOC HEMATOLOGY.

Entercoccal endocarditis, spondylodiskitis, and bacteremia.

Mason, M and Deitelzweig, S (2002). Entercoccal endocarditis, spondylodiskitis, and bacteremia.. BLACKWELL PUBLISHING INC.

Utility of Transjugular Liver-Biopsy (Tjlb) in the Diagnosis of Fulminant Hepatic-Failure (Fhf) Secondary to Metastatic Carcinoma (Mc)

Deitelzweig, S, Yoselevitz, M and Regenstein, FG (1994). Utility of Transjugular Liver-Biopsy (Tjlb) in the Diagnosis of Fulminant Hepatic-Failure (Fhf) Secondary to Metastatic Carcinoma (Mc). W B SAUNDERS CO.